Predictors of Steroid Failure and Outcomes of Rescue Therapy in Severe ICI-Induced Colitis: A Multicenter Study from GETECCU
Digestive Diseases and Sciences · 2026-11 · 71 (11) · 5754-5763
DOI: 10.1007/s10620-026-10118-1 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Digestive Diseases and Sciences, online erschienen am 29.07.2026. Verfasst von Cristina Polo Cuadro und 53 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Aparato Digestivo, Instituto de Investigación Sanitaria de Aragón, Hospital Universitario Miguel Servet, Paseo Isabel la Católica 1-3, 50…. Hauptthemen laut MEDLINE: Adrenal Cortex Hormones, Colitis, Immune Checkpoint Inhibitors, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Instituto de Salud Carlos III.
Abstract (Originalsprache)
Introduction
Immune checkpoint inhibitors (ICIs) have transformed cancer therapy but are frequently associated with immune-mediated colitis (IMC), a potentially severe complication. However, evidence on treatment effectiveness and predictors of response is limited. Materials and Methods We conducted a multicenter, retrospective study promoted by GETECCU including adult patients with solid tumors who developed grade 3–4 IMC requiring hospitalization between 2014 and 2024. All patients received intravenous corticosteroids; those refractory to steroids could receive targeted therapies. Clinical symptoms were assessed using a modified partial Mayo score including abdominal pain, and endoscopic activity was evaluated with the UCEIS index. Treatment failure was defined as the need for rescue therapy, surgery, or death.
Results
We included 211 patients (40% women, mean age 62 years). Corticosteroid response was achieved in 50.2% of cases. Non-responders had shorter time to IMC onset, prior outpatient steroid use, higher symptom severity, and more frequent moderate-to-severe endoscopic findings. Independent predictors of corticosteroid failure were prior oral corticosteroid use (OR 4.4), higher UCEIS score (OR 1.31), and higher modified Mayo score (OR 1.45). A total of 113 rescue therapies were administered, primarily infliximab, vedolizumab, or ustekinumab, with overall effectiveness rates of 65–72%. Clinical severity was the only factor associated with reduced response to rescue therapy.
Conclusion
Corticosteroid efficacy in severe IMC is limited. Clinical symptom severity and endoscopic ulcerations predict poor response to corticosteroids, while symptom severity also influences outcomes of biologic rescue therapy. Early identification of high-risk patients may improve treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Servicio de Aparato Digestivo, Instituto de Investigación Sanitaria de Aragón, Hospital Universitario Miguel Servet, Paseo Isabel la Católica 1-3, 50009, Saragossa, Spain.
- Servicio de Oncología Médica, Hospital Universitario Miguel Servet, Instituto de Investigación Sanitaria de Aragón, Zaragoza, Spain.
- Servicio de Aparato digestivo, Hospital Clínico Universitario de Santiago de Compostela, Santiago, Spain.
- Servicio de Aparato digestivo, Hospital Universitari Germans Trias i Pujol, CIBERehd, Badalona, Spain.
- Servicio de Aparato digestivo, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Llobregat, Spain.
- CIBERhed, Hospital Universitari Mútua de Terrassa, Terrassa, Spain.
ORCID-Profile: Diego Casas Deza
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Polo Cuadro, C., Gascón Ruiz, M., Barreiro, M., Mañosa, M., Rodríguez Moranta, F., Zabana, Y., Céspedes Martínez, E., Ordás, I., Miranda Bautista, J., García, M. J., García de la Filia Molina, I., Roig Ramos, C., Ruiz Cerulla, A., Segarra Ortega, J. X., Matallana Royo, V., Rodríguez González, G. E., Martínez de Juan, F., Manceñido Marcos, N., Madero Velázquez, L., …, & GETECCU (2026). Predictors of Steroid Failure and Outcomes of Rescue Therapy in Severe ICI-Induced Colitis: A Multicenter Study from GETECCU. Digestive Diseases and Sciences, 71(11), 5754-5763. https://doi.org/10.1007/s10620-026-10118-1
Vancouver
Polo Cuadro C, Gascón Ruiz M, Barreiro M, Mañosa M, Rodríguez Moranta F, Zabana Y, et al. Predictors of Steroid Failure and Outcomes of Rescue Therapy in Severe ICI-Induced Colitis: A Multicenter Study from GETECCU. Digestive Diseases and Sciences. 2026;71(11):5754-5763. doi:10.1007/s10620-026-10118-1
BibTeX
@article{PoloCuadro2026,
author = {Polo Cuadro, Cristina and Gascón Ruiz, Marta and Barreiro, Manuel and Mañosa, Míriam and Rodríguez Moranta, Francisco and Zabana, Yamile and Céspedes Martínez, Elena and Ordás, Ingrid and Miranda Bautista, José and García, María José and García de la Filia Molina, Irene and Roig Ramos, Cristina and Ruiz Cerulla, Alexandra and Segarra Ortega, José Xavier and Matallana Royo, Virginia and Rodríguez González, G Esther and Martínez de Juan, Fernando and Manceñido Marcos, Noemí and Madero Velázquez, Lucía and Betoré Glaría, Elena and Álvarez Herrero, Begoña and Suris, Gerard and Garrido Marín, Alejandro and Brunet Mas, Eduard and Alonso Abreu, Inmaculada and Santos Fernández, Javier and Vaamonde Lorenzo, María and Almingol Crespo, Cristina and Folguera, Carla and Sanz Segura, Patricia and Moralejo Lozano, Óscar and López Couceiro, Laura and Tejido Sandoval, Coral and Mena Sánchez, Raquel and Sainz, Empar and Marquès Camí, Miquel and Ferreiro Iglesias, Rocío and Ortega Moya, Silvia Patricia and Wolfe García, Pablo Miles and Borras Garriga, Pere and Herreros Martínez, Belén and Calvo, María and Frago Larramona, Santiago and Ladrón Abia, Pablo and Gargallo Puyuelo, Carla J and Serra, Xavier and Menchén, Luis and Rivas, Coral and Mesonero Gismero, Francisco and Vicente Lidón, Raquel and Gutierrez, Ana and García López, Santiago and Casas Deza, Diego and GETECCU, GETECCU},
title = {Predictors of Steroid Failure and Outcomes of Rescue Therapy in Severe ICI-Induced Colitis: A Multicenter Study from GETECCU},
journal = {Digestive Diseases and Sciences},
year = {2026},
volume = {71},
number = {11},
pages = {5754--5763},
doi = {10.1007/s10620-026-10118-1}
}
EUVIMED